ASLN
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN
Delisted
ASLN was delisted on the 18th of July, 2024.
19 hedge funds and large institutions have $10.5M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less capital invested
Capital invested by funds: $24.6M → $10.5M (-$14.1M)
Holders
19
Holding in Top 10
–
Calls
$8K
Puts
$3K
Top Buyers
| 1 | +$1.45M | |
| 2 | +$1.18M | |
| 3 | +$69.8K | |
| 4 |
Renaissance Technologies
New York
|
+$8.86K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$433 |
Top Sellers
| 1 | -$4.27M | |
| 2 | -$252K | |
| 3 | -$219K | |
| 4 |
Millennium Management
New York
|
-$109K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$60.4K |